Ironwood Pharmaceuti (IRWD) Stock Price, Quote & News

Company Profile

Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally. It markets linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation, as well as for pediatric patients suffering from functional constipation under the LINZESS and CONSTELLA na...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 617 621 7722

Fax: 617 494 0480

Website: ironwoodpharma.com

Address:

100 Summer Street, Suite 2300, Boston, United States

revuelto Dec. 6 at 4:57 PM

$IRWD if Tom et al can deliver a 5× from here, the wait will absolutely be worth it ✌️

1 · Reply

Bio_Invest101 Dec. 6 at 11:28 AM

$IRWD https://www.fiercepharma.com/pharma/biopharma-dealmaking-landscape-and-what-expect-2026

0 · Reply

buymoremakemore Dec. 6 at 2:22 AM

$IRWD Cmon guys https://x.com/seedy19tron/status/1997080305862431072?s=20

0 · Reply

Bio_Invest101 Dec. 5 at 9:44 PM

$IRWD For some who don’t have access to X here are the 4 page copies from Mr Duhan Better time ahead and Enjoy your weekend

0 · Reply

raylin Dec. 5 at 9:44 PM

$IRWD Can we get some BO rumors? Update on P3 redo plan?

0 · Reply

Bio_Invest101 Dec. 5 at 9:37 PM

$IRWD Patience pays. And we all have a lot to learn from the excellent Turkey CFA https://x.com/dsakdag/status/1996496703776542850?s=46&t=0dxFfv8Iw4yOBhPO0oZagA

0 · Reply

VSTN Dec. 5 at 7:25 PM

$IRWD Market Cap $560M…. I’ve seen companies with pipelines nothing past phase 1 and no approved drugs with higher valuations. We wait

1 · Reply

Nibbler Dec. 5 at 5:58 PM

$IRWD I believe we closed around $1.92 three Fridays ago. I just keep reminding myself of that.

1 · Reply

Itinerant Dec. 5 at 5:52 PM

$IRWD Price behavior seems rather volatile today. Why would that be? Maybe it is must range trading, but I wonder why anyone would bother with range trades when the take out is likely at much higher price. Opinions?

1 · Reply

ASKING7 Dec. 5 at 5:11 PM

$IRWD Loading

0 · Reply

Ironwood Pharmaceuticals: Today's Gains Seem Sustainable After Disastrous First Half Of 2025

Nov 10, 2025, 7:05 AM EST - 27 days ago

Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance

Oct 24, 2025, 8:10 AM EDT - 6 weeks ago

Ironwood Stair & Rail Inc. Recognised With 2025 Consumer Choice Award for Stairs and Railings in Southern Alberta

Aug 7, 2025, 9:44 AM EDT - 4 months ago

Ironwood (IRWD) Q2 EPS Jumps 600%

Aug 7, 2025, 7:05 AM EDT - 4 months ago

Ironwood Pharmaceuticals Reports Second Quarter 2025 Results; Maintains Full Year 2025 Financial Guidance

May 7, 2025, 7:05 AM EDT - 7 months ago

Ironwood Pharmaceuticals Reports First Quarter 2025 Results

Apr 30, 2025, 4:25 PM EDT - 7 months ago

Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference

Apr 25, 2025, 7:05 AM EDT - 8 months ago

Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance

Apr 22, 2025, 4:05 PM EDT - 8 months ago

Ironwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week® 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral Support

Apr 14, 2025, 2:19 PM EDT - 8 months ago

Ironwood Pharmaceuticals Stock Plunges, FDA Wants Another Trial For Gastrointestinal Drug

Apr 14, 2025, 7:00 AM EDT - 8 months ago

Ironwood Pharmaceuticals Provides Clinical and Regulatory Update on Apraglutide

Apr 10, 2025, 10:49 AM EDT - 8 months ago

Ironwood Pharmaceuticals: Setting A Strong Foundation For A Return To Growth

Mar 27, 2025, 4:05 PM EDT - 9 months ago

Ironwood Pharmaceuticals Announces Receipt of Nasdaq Non-Compliance Notification Regarding Late 2024 Form 10-K Filing

Mar 25, 2025, 8:30 AM EDT - 9 months ago

Industry Veteran Launches Ironwood III With Substantial Equity Commitment From Kayne Anderson Energy Infrastructure Fund

Feb 27, 2025, 11:21 AM EST - 10 months ago

Ironwood Pharmaceuticals, Inc. (IRWD) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 7:00 AM EST - 10 months ago

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; Achieves 2024 Financial Guidance

Feb 20, 2025, 4:00 PM EST - 10 months ago

Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call

Jan 29, 2025, 4:05 PM EST - 11 months ago

Ironwood Pharmaceuticals Initiates Apraglutide NDA Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future

Jan 17, 2025, 8:07 AM EST - 11 months ago

Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications

Nov 26, 2024, 4:01 PM EST - 1 year ago

Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nov 13, 2024, 4:01 PM EST - 1 year ago

Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference

Nov 7, 2024, 10:34 PM EST - 1 year ago

Ironwood Pharmaceuticals, Inc. (IRWD) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 7:00 AM EST - 1 year ago

Ironwood Pharmaceuticals Reports Third Quarter 2024 Results

Oct 28, 2024, 7:00 AM EDT - 1 year ago

Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024

Oct 24, 2024, 4:00 PM EDT - 1 year ago

Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call

Aug 29, 2024, 4:01 PM EDT - 1 year ago

Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference

Aug 9, 2024, 12:10 PM EDT - 1 year ago

Ironwood Pharmaceuticals, Inc. (IRWD) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 7:00 AM EDT - 1 year ago

Ironwood Pharmaceuticals Reports Second Quarter 2024 Results

Jul 25, 2024, 4:00 PM EDT - 1 year ago

Ironwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call

Jun 28, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Starts Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Begin Conversation

Jun 26, 2024, 3:30 PM EDT - 1 year ago

The Schall Law Firm Initiates Inquiry Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors Who Incurred Losses To Initiate Dialogue

Jun 25, 2024, 2:45 PM EDT - 1 year ago

The Schall Law Firm Initiates Probe Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors Who Suffered Losses To Initiate Contact

Jun 24, 2024, 4:45 PM EDT - 1 year ago

The Schall Law Firm Begins Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Establish Communication

Jun 23, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Initiates Probe Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors With Losses To Connect

Jun 22, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Begins Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Reach Out

Jun 20, 2024, 1:00 PM EDT - 1 year ago

Ironwood Pharmaceuticals: Q3 Of 2024 Data Readout For PBC

Jun 19, 2024, 4:20 PM EDT - 1 year ago

Allegations Against Ironwood Pharmaceuticals Inc The Schall Law Firm Initiates Probe And Urges Investors With Losses To Make Contact

Jun 18, 2024, 4:00 PM EDT - 1 year ago

Claims Against Ironwood Pharmaceuticals Inc The Schall Law Firm Begins Investigation And Encourages Investors With Losses To Reach Out

Jun 11, 2024, 7:00 PM EDT - 1 year ago

Claims Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Begins Investigation And Encourages Investors With Losses To Reach Out

Jun 9, 2024, 11:00 AM EDT - 1 year ago

Claims Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Begins Investigation And Urges Investors With Losses To Contact Them

Jun 8, 2024, 11:00 AM EDT - 1 year ago

Allegations Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Initiates Probe And Invites Investors With Losses To Get In Touch

Jun 7, 2024, 3:00 PM EDT - 1 year ago

Claims Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Begins Investigation And Encourages Investors With Losses To Contact Them

Jun 6, 2024, 1:00 PM EDT - 1 year ago

Accusations Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Initiates Investigation And Invites Investors With Losses To Reach Out

Jun 5, 2024, 1:30 PM EDT - 1 year ago

Ironwood Pharmaceuticals, Inc. Accusations: Schall Law Firm Announces Investigation and Calls for Investors with Losses to Connect

Jun 4, 2024, 3:00 PM EDT - 1 year ago

The Schall Law Firm Declares an Inquiry into Accusations Against Ironwood Pharmaceuticals, Inc. and Advocates for Investors with Losses to Reach Out

Jun 2, 2024, 11:00 AM EDT - 1 year ago

ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Ironwood Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

May 31, 2024, 6:15 PM EDT - 1 year ago

ONGOING INVESTIGATION UPDATE: The Schall Law Firm Announces it is Investigating Claims Against Ironwood Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

May 30, 2024, 4:01 PM EDT - 1 year ago

Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

revuelto Dec. 6 at 4:57 PM

$IRWD if Tom et al can deliver a 5× from here, the wait will absolutely be worth it ✌️

1 · Reply

Bio_Invest101 Dec. 6 at 11:28 AM

$IRWD https://www.fiercepharma.com/pharma/biopharma-dealmaking-landscape-and-what-expect-2026

0 · Reply

buymoremakemore Dec. 6 at 2:22 AM

$IRWD Cmon guys https://x.com/seedy19tron/status/1997080305862431072?s=20

0 · Reply

Bio_Invest101 Dec. 5 at 9:44 PM

$IRWD For some who don’t have access to X here are the 4 page copies from Mr Duhan Better time ahead and Enjoy your weekend

0 · Reply

raylin Dec. 5 at 9:44 PM

$IRWD Can we get some BO rumors? Update on P3 redo plan?

0 · Reply

Bio_Invest101 Dec. 5 at 9:37 PM

$IRWD Patience pays. And we all have a lot to learn from the excellent Turkey CFA https://x.com/dsakdag/status/1996496703776542850?s=46&t=0dxFfv8Iw4yOBhPO0oZagA

0 · Reply

VSTN Dec. 5 at 7:25 PM

$IRWD Market Cap $560M…. I’ve seen companies with pipelines nothing past phase 1 and no approved drugs with higher valuations. We wait

1 · Reply

Nibbler Dec. 5 at 5:58 PM

$IRWD I believe we closed around $1.92 three Fridays ago. I just keep reminding myself of that.

1 · Reply

Itinerant Dec. 5 at 5:52 PM

1 · Reply

ASKING7 Dec. 5 at 5:11 PM

$IRWD Loading

0 · Reply

mkmike396 Dec. 5 at 4:03 PM

$IRWD going to be bumpy, forget it and look again in 6 months

0 · Reply

King_Chase Dec. 5 at 3:32 PM

$IRWD A dangerous Game is being played here... Somehow I can't trade my 8000 shares in the 3,70's last days - because I think this is a last attempt to push weak traders out of their shares before moving up...

0 · Reply

TeeMan123 Dec. 5 at 3:22 PM

$IRWD $11 let’s get this done already

0 · Reply

AeroSmith Dec. 5 at 3:15 PM

$IRWD Chart says, I want to pull back. Valuation says, I want to go higher. Reckon I'm holding and buying on any pullback to the 21 day. 10x last Q's EBITDA is 35% higher from here.

1 · Reply

VSTN Dec. 5 at 2:50 PM

$IRWD We doing this shit again. lol

0 · Reply

dubliner1967 Dec. 5 at 2:46 PM

$IRWD Rick Pazdur's resignation is quite the development too... https://www.politico.com/news/2025/12/02/the-fdas-top-drug-regulator-submits-his-resignation-to-the-agency-00672818

1 · Reply

Nibbler Dec. 4 at 10:35 PM

$IRWD I hope that Makary news release is good news for us.

0 · Reply

mkmike396 Dec. 4 at 8:47 PM

$IRWD got enough in this one that my mood basically follows the price. Happy ending today!

0 · Reply

TeeMan123 Dec. 4 at 8:34 PM

$IRWD give us the news already… clearly this stock has news they are not sharing

1 · Reply

Bazzzigar Dec. 4 at 7:09 PM

$IRWD HIMS

0 · Reply

ASKING7 Dec. 4 at 5:00 PM

$IRWD setting up for the next round up and we should re-test then break out $4 this time.

0 · Reply

noturfinancrbro Dec. 4 at 4:53 PM

$IRWD I love it when its down with low volume 😋

0 · Reply

Market Cap	566.12M
Revenue (ttm)	351.41M
Net Income (ttm)	880,000.00
EPS (ttm)	N/A
PE Ratio	14.35
Forward PE	14.07
Profit Margin	0.25%
Debt to Equity Ratio	-2.21

Volume	2,062,300
Avg Vol	2,305,534
Day's Range	N/A - N/A
Shares Out	162.68M
Stochastic %K	48%
Beta	0.18
Analysts	Hold
Price Target	$2.38